The Administrative Core will be critical in providing overall leadership and central administrative support to the Chemistry Center, including establishing and implementing, in collaboration with center staff, assay providers and the NIH Network Science Officer, a Compound Probe Development Plan (CPDP) for each program. One of the most critical functions of the Administrative Core will be communication with other Centers within the MLPCN, including coordination of studies, transfer of compounds, and efficient communication of data to facilitate iterative compound synthesis and testing. In addition, the Administrative Core will be responsible for organization for all Center meetings, travel arrangements for attendance of MLPCN meetings, preparation of progress reports and noncompetitive renewal applications. Finally, the administrative core will be responsible for recruitment and staffing as well as budgetary management of the Program. The following specific aims summarize the major functions of the administrative core:
AIM 1. To establish goals of each probe optimization effort and initiate probe optimization by assigning lead chemist and coordinating communication between the Vanderbilt chemistry center, other MLPCN centers, the MLSMR, and the NIH program administrators.
AIM 2. To effectively manage the integration of activities of medicinal chemistry, informatics and pharmacology components within the Vanderbilt Specialized Chemistry Center.
AIM 3. To coordinate and manage communication and transfer of reagents, data and novel probes to the scientific community.
AIM 4. To recruit and maintain staff for the proposed MLPCN facility to support and advance the MLPCN goals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54MH084659-06
Application #
8517186
Study Section
Special Emphasis Panel (ZRG1-IFCN-K)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
6
Fiscal Year
2013
Total Cost
$94,915
Indirect Cost
$40,026
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Oliver, Kendra H; Duvernay, Matthew T; Hamm, Heidi E et al. (2016) Loss of Serotonin Transporter Function Alters ADP-mediated Glycoprotein αIIbβ3 Activation through Dysregulation of the 5-HT2A Receptor. J Biol Chem 291:20210-9
Wood, Michael R; Noetzel, Meredith J; Tarr, James C et al. (2016) Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition. Bioorg Med Chem Lett 26:4282-6
Niswender, Colleen M; Jones, Carrie K; Lin, Xin et al. (2016) Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers. ACS Chem Neurosci 7:1201-11
Garcia-Barrantes, Pedro M; Cho, Hyekyung P; Blobaum, Anna L et al. (2016) Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 3. Engineering plasma stability by discovery and optimization of isoindolinone analogs. Bioorg Med Chem Lett 26:1869-72
Garcia-Barrantes, Pedro M; Cho, Hyekyung P; Metts, Adam M et al. (2016) Lead optimization of the VU0486321 series of mGlu(1) PAMs. Part 2: SAR of alternative 3-methyl heterocycles and progress towards an in vivo tool. Bioorg Med Chem Lett 26:751-6
Wood, Michael R; Noetzel, Meredith J; Poslusney, Michael S et al. (2016) Challenges in the development of an M4 PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogs. Bioorg Med Chem Lett :
Garcia-Barrantes, Pedro M; Cho, Hyekyung P; Starr, Tahj M et al. (2016) Re-exploration of the mGlu₁ PAM Ro 07-11401 scaffold: Discovery of analogs with improved CNS penetration despite steep SAR. Bioorg Med Chem Lett 26:2289-92
Wood, Michael R; Noetzel, Meredith J; Engers, Julie L et al. (2016) Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core. Bioorg Med Chem Lett 26:3029-33
Wu, Yang; Stauffer, Shaun R; Stanfield, Robyn L et al. (2016) Discovery of Small-Molecule Nonfluorescent Inhibitors of Fluorogen-Fluorogen Activating Protein Binding Pair. J Biomol Screen 21:74-87
An, Hanbing; Stoops, Sydney L; Deane, Natasha G et al. (2015) Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition. Oncotarget 6:22934-48

Showing the most recent 10 out of 137 publications